Contact Us
Attention Deficit Hyperactivity Disorder Global Market Report 2025
Global Attention Deficit Hyperactivity Disorder Market Report 2025
Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Attention Deficit Hyperactivity Disorder Global Market Report 2025

By Type (Stimulants, Non-Stimulants), By Age Group (Children, Adults), By Gender (Male, Female), By Dosage Form (Tablets, Capsules, Other Dosage Forms), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Attention Deficit Hyperactivity Disorder Market Overview

• Attention Deficit Hyperactivity Disorder market size has reached to $16.29 billion in 2024

• Expected to grow to $22.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%

• Growth Driver: The Growing Adoption Of Personalized Medicine Is Driving The Market

• Market Trend: JAMP Pharma Group Expands ADHD Treatment Options With Launch Of Guanfacine XR

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Attention Deficit Hyperactivity Disorder Market?

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition characterized by persistent inattention, hyperactivity, and impulsivity that interfere with daily functioning. It begins in childhood and can continue into adulthood, affecting focus, self-control, and organization. Treatment may include behavioral therapy, medication, and lifestyle adjustments.

The main types of attention deficit hyperactivity disorder (ADHD) treatment include stimulants and non-stimulants. Stimulants are medications that enhance brain activity to improve focus, attention, and impulse control, commonly used for ADHD treatment. ADHD treatment is categorized by age group into children and adults, and by gender into male and female. ADHD drugs are available in various dosage forms, including tablets, capsules, and other forms, and are distributed through multiple channels, such as retail pharmacies, hospital pharmacies, and online pharmacies.

Attention Deficit Hyperactivity Disorder Market Size and growth rate 2025 to 2029: Graph

What Is The Attention Deficit Hyperactivity Disorder Market Size 2025 And Growth Rate?

The attention deficit hyperactivity disorder market size has grown strongly in recent years. It will grow from $16.29 billion in 2024 to $17.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising prevalence of ADHD, growing incidence of ADHD in children, and increasing awareness of ADHD, increasing healthcare expenditure, government initiatives for mental health awareness.

What Is The Attention Deficit Hyperactivity Disorder Market Growth Forecast?

The attention deficit hyperactivity disorder market size is expected to see strong growth in the next few years. It will grow to $22.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing pediatric and adult patient populations receiving treatment, advanced healthcare infrastructure, growing adoption of personalized medicine, growing acceptance of mental health issues, and rising use of additives and preservatives in children’s diet. Major trends in the forecast period include improvements in technology and innovative treatments, advancements in diagnostic and treatment methods, development of new therapeutic agents, shift towards non-stimulant medications, and advancements in pharmaceutical treatments.

The forecast of 6.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. mental healthcare by increasing the cost of extended-release stimulant medications and digital therapeutic apps sourced from Israel and Canada, thereby reducing treatment adherence and elevating pediatric psychiatry expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Attention Deficit Hyperactivity Disorder Market Segmented?

1) By Type: Stimulants, Non-Stimulants

2) By Age Group: Children, Adults

3) By Gender: Male, Female

4) By Dosage Form: Tablets, Capsules, Other Dosage Forms

5) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy

Subsegments:

1) By Stimulants: Methylphenidate-based Medications, Amphetamine-based Medications, Mixed Amphetamine Salts, Dexmethylphenidate

2) By Non-Stimulants: Atomoxetine (Strattera), Guanfacine (Intuniv), Clonidine (Kapvay), Bupropion (Wellbutrin)

What Is Driving The Attention Deficit Hyperactivity Disorder Market? The Growing Adoption Of Personalized Medicine Is Driving The Market

The growing adoption of personalized medicine is expected to propel the growth of the attention deficit hyperactivity disorder (ADHD) market going forward. Personalized medicine is a medical approach that tailors’ treatments to an individual's genetic, environmental, and lifestyle factors for more precise and effective healthcare. The adoption of personalized medicine is attributed to advancements in genomic technologies, which enable the tailoring of treatments based on an individual's genetic profile, leading to more effective and targeted therapies. Attention deficit hyperactivity disorder (ADHD) contributes significantly to personalized medicine by facilitating customized treatment strategies that consider an individual’s unique genetic, environmental, and behavioral characteristics, resulting in more effective and targeted interventions. For instance, in February 2024, according to a report published by the Personalized Medicine Coalition (PMC), a US-based non-profit organization, in 2023, personalized medicines accounted for over a third of new FDA drug approvals for the fourth consecutive year. The FDA approved 16 new personalized treatments for rare diseases (up from 6 in 2022), 7 cancer drugs, and 3 for other conditions. Therefore, the growing adoption of personalized medicine is driving the growth of the attention deficit hyperactivity disorder industry.

Who Are The Major Players In The Global Attention Deficit Hyperactivity Disorder Market?

Major companies operating in the attention deficit hyperactivity disorder market are Pfizer Inc., Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Neos Therapeutics Inc., Collegium Pharmaceutical Inc., Mallinckrodt Pharmaceuticals plc, Tris Pharma Inc., Arbor Pharmaceuticals LLC, Akili Interactive Labs Inc., Mind Medicine (MindMed) Inc., NeuroSigma Inc., KemPharm Inc., RespireRx Pharmaceuticals Inc., Cingulate Therapeutics LLC, Adlon Therapeutics L.P.

What Are The Key Trends Of The Global Attention Deficit Hyperactivity Disorder Market? JAMP Pharma Group Expands ADHD Treatment Options With Launch Of Guanfacine XR

Major companies operating in the attention deficit hyperactivity disorder (ADHD) market are focusing on developing innovative drugs, such as extended-release tablets, to improve treatment efficacy, enhance patient compliance, and provide long-lasting symptom control. Extended-release tablets are designed to release medication gradually over time, providing consistent symptom control throughout the day with a single dose, which reduces the need for multiple doses and improves convenience and adherence to the treatment plan for individuals with attention deficit hyperactivity disorder (ADHD). For instance, in February 2022, JAMP Pharma Group, a Canada-based pharmaceutical company, launched Guanfacine XR, a generic form of Takeda Canada Inc.'s INTUNIV XR, a branded medication intended to treat attention deficit hyperactivity disorder (ADHD). It is a long-acting form of guanfacine, which works by affecting certain receptors in the brain to improve attention, impulse control, and hyperactivity. The drug is available in multiple strengths (1 mg, 2 mg, 3 mg, and 4 mg) and comes in a 100-count bottle, providing flexibility for treatment.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Attention Deficit Hyperactivity Disorder Market? Collegium Pharmaceutical Expands Into ADHD Market With Acquisition Of Ironshore Therapeutics

In September 2024, Collegium Pharmaceutical Inc., a US-based specialty pharmaceutical company, acquired Ironshore Therapeutics Inc. for $525 million. This acquisition aims to expand its product portfolio beyond pain management and establish a presence in the growing ADHD market with the differentiated product Jornay PM. Ironshore Therapeutics Inc. is a US-based company focused on developing and commercializing therapies for attention deficit hyperactivity disorder (ADHD).

What Is The Regional Outlook For The Global Attention Deficit Hyperactivity Disorder Market?

North America was the largest region in the attention deficit hyperactivity disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Attention Deficit Hyperactivity Disorder  Market?

The attention deficit hyperactivity disorder market consists of revenues earned by entities by providing services such as diagnosis, therapy, counselling, medication management, and digital health solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The attention deficit hyperactivity disorder (ADHD) market also includes sales of medical devices, digital therapeutics, and assistive learning tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Attention Deficit Hyperactivity Disorder  Industry?

The attention deficit hyperactivity disorder market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the attention deficit hyperactivity disorder industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Attention Deficit Hyperactivity Disorder Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $17.38 billion
Revenue Forecast In 2034 $22.42 billion
Growth Rate CAGR of 6.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The attention deficit hyperactivity disorder market covered in this report is segmented –
1) By Type: Stimulants, Non-Stimulants
2) By Age Group: Children, Adults
3) By Gender: Male, Female
4) By Dosage Form: Tablets, Capsules, Other Dosage Forms
5) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy Subsegments:
1) By Stimulants: Methylphenidate-based Medications, Amphetamine-based Medications, Mixed Amphetamine Salts, Dexmethylphenidate
2) By Non-Stimulants: Atomoxetine (Strattera), Guanfacine (Intuniv), Clonidine (Kapvay), Bupropion (Wellbutrin)
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Neos Therapeutics Inc., Collegium Pharmaceutical Inc., Mallinckrodt Pharmaceuticals plc, Tris Pharma Inc., Arbor Pharmaceuticals LLC, Akili Interactive Labs Inc., Mind Medicine (MindMed) Inc., NeuroSigma Inc., KemPharm Inc., RespireRx Pharmaceuticals Inc., Cingulate Therapeutics LLC, Adlon Therapeutics L.P.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Attention Deficit Hyperactivity Disorder Market Characteristics

3. Attention Deficit Hyperactivity Disorder Market Trends And Strategies

4. Attention Deficit Hyperactivity Disorder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Attention Deficit Hyperactivity Disorder Growth Analysis And Strategic Analysis Framework

5.1. Global Attention Deficit Hyperactivity Disorder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Attention Deficit Hyperactivity Disorder Market Growth Rate Analysis

5.4. Global Attention Deficit Hyperactivity Disorder Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Attention Deficit Hyperactivity Disorder Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Attention Deficit Hyperactivity Disorder Total Addressable Market (TAM)

6. Attention Deficit Hyperactivity Disorder Market Segmentation

6.1. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stimulants

Non-Stimulants

6.2. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Children

Adults

6.3. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Male

Female

6.4. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Capsules

Other Dosage Forms

6.5. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

6.6. Global Attention Deficit Hyperactivity Disorder Market, Sub-Segmentation Of Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Methylphenidate-based Medications

Amphetamine-based Medications

Mixed Amphetamine Salts

Dexmethylphenidate

6.7. Global Attention Deficit Hyperactivity Disorder Market, Sub-Segmentation Of Non-Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Atomoxetine (Strattera)

Guanfacine (Intuniv)

Clonidine (Kapvay)

Bupropion (Wellbutrin)

7. Attention Deficit Hyperactivity Disorder Market Regional And Country Analysis

7.1. Global Attention Deficit Hyperactivity Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Attention Deficit Hyperactivity Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Attention Deficit Hyperactivity Disorder Market

8.1. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Attention Deficit Hyperactivity Disorder Market

9.1. China Attention Deficit Hyperactivity Disorder Market Overview

9.2. China Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Attention Deficit Hyperactivity Disorder Market

10.1. India Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Attention Deficit Hyperactivity Disorder Market

11.1. Japan Attention Deficit Hyperactivity Disorder Market Overview

11.2. Japan Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Attention Deficit Hyperactivity Disorder Market

12.1. Australia Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Attention Deficit Hyperactivity Disorder Market

13.1. Indonesia Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Attention Deficit Hyperactivity Disorder Market

14.1. South Korea Attention Deficit Hyperactivity Disorder Market Overview

14.2. South Korea Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Attention Deficit Hyperactivity Disorder Market

15.1. Western Europe Attention Deficit Hyperactivity Disorder Market Overview

15.2. Western Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Attention Deficit Hyperactivity Disorder Market

16.1. UK Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Attention Deficit Hyperactivity Disorder Market

17.1. Germany Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Attention Deficit Hyperactivity Disorder Market

18.1. France Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Attention Deficit Hyperactivity Disorder Market

19.1. Italy Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Attention Deficit Hyperactivity Disorder Market

20.1. Spain Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Attention Deficit Hyperactivity Disorder Market

21.1. Eastern Europe Attention Deficit Hyperactivity Disorder Market Overview

21.2. Eastern Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Attention Deficit Hyperactivity Disorder Market

22.1. Russia Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Attention Deficit Hyperactivity Disorder Market

23.1. North America Attention Deficit Hyperactivity Disorder Market Overview

23.2. North America Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Attention Deficit Hyperactivity Disorder Market

24.1. USA Attention Deficit Hyperactivity Disorder Market Overview

24.2. USA Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Attention Deficit Hyperactivity Disorder Market

25.1. Canada Attention Deficit Hyperactivity Disorder Market Overview

25.2. Canada Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Attention Deficit Hyperactivity Disorder Market

26.1. South America Attention Deficit Hyperactivity Disorder Market Overview

26.2. South America Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Attention Deficit Hyperactivity Disorder Market

27.1. Brazil Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Attention Deficit Hyperactivity Disorder Market

28.1. Middle East Attention Deficit Hyperactivity Disorder Market Overview

28.2. Middle East Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Attention Deficit Hyperactivity Disorder Market

29.1. Africa Attention Deficit Hyperactivity Disorder Market Overview

29.2. Africa Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Attention Deficit Hyperactivity Disorder Market Competitive Landscape And Company Profiles

30.1. Attention Deficit Hyperactivity Disorder Market Competitive Landscape

30.2. Attention Deficit Hyperactivity Disorder Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Attention Deficit Hyperactivity Disorder Market Other Major And Innovative Companies

31.1. Eli Lilly and Company

31.2. Teva Pharmaceutical Industries Ltd.

31.3. Otsuka Pharmaceutical Co. Ltd.

31.4. Supernus Pharmaceuticals Inc.

31.5. Neos Therapeutics Inc.

31.6. Collegium Pharmaceutical Inc.

31.7. Mallinckrodt Pharmaceuticals plc

31.8. Tris Pharma Inc.

31.9. Arbor Pharmaceuticals LLC

31.10. Akili Interactive Labs Inc.

31.11. Mind Medicine (MindMed) Inc.

31.12. NeuroSigma Inc.

31.13. KemPharm Inc.

31.14. RespireRx Pharmaceuticals Inc.

31.15. Cingulate Therapeutics LLC

32. Global Attention Deficit Hyperactivity Disorder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Attention Deficit Hyperactivity Disorder Market

34. Recent Developments In The Attention Deficit Hyperactivity Disorder Market

35. Attention Deficit Hyperactivity Disorder Market High Potential Countries, Segments and Strategies

35.1 Attention Deficit Hyperactivity Disorder Market In 2029 - Countries Offering Most New Opportunities

35.2 Attention Deficit Hyperactivity Disorder Market In 2029 - Segments Offering Most New Opportunities

35.3 Attention Deficit Hyperactivity Disorder Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Attention Deficit Hyperactivity Disorder Market, Sub-Segmentation Of Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Attention Deficit Hyperactivity Disorder Market, Sub-Segmentation Of Non-Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Attention Deficit Hyperactivity Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Attention Deficit Hyperactivity Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Johnson & Johnson Financial Performance
  • Table 80: AstraZeneca PLC Financial Performance
  • Table 81: Novartis International AG Financial Performance
  • Table 82: Takeda Pharmaceutical Company Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Attention Deficit Hyperactivity Disorder Market, Sub-Segmentation Of Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Attention Deficit Hyperactivity Disorder Market, Sub-Segmentation Of Non-Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Attention Deficit Hyperactivity Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Attention Deficit Hyperactivity Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Johnson & Johnson Financial Performance
  • Figure 80: AstraZeneca PLC Financial Performance
  • Figure 81: Novartis International AG Financial Performance
  • Figure 82: Takeda Pharmaceutical Company Limited Financial Performance

Frequently Asked Questions

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition characterized by persistent inattention, hyperactivity, and impulsivity that interfere with daily functioning. It begins in childhood and can continue into adulthood, affecting focus, self-control, and organization. Treatment may include behavioral therapy, medication, and lifestyle adjustments. For further insights on this market, request a sample here

The market major growth driver - The Growing Adoption Of Personalized Medicine Is Driving The Market. For further insights on this market, request a sample here

The attention deficit hyperactivity disorder market size has grown strongly in recent years. It will grow from $16.29 billion in 2024 to $17.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising prevalence of ADHD, growing incidence of ADHD in children, and increasing awareness of ADHD, increasing healthcare expenditure, government initiatives for mental health awareness. The attention deficit hyperactivity disorder market size is expected to see strong growth in the next few years. It will grow to " $22.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing pediatric and adult patient populations receiving treatment, advanced healthcare infrastructure, growing adoption of personalized medicine, growing acceptance of mental health issues, and rising use of additives and preservatives in children’s diet. Major trends in the forecast period include improvements in technology and innovative treatments, advancements in diagnostic and treatment methods, development of new therapeutic agents, shift towards non-stimulant medications, and advancements in pharmaceutical treatments. For further insights on this market, request a sample here

The attention deficit hyperactivity disordermarket covered in this report is segmented –
1) By Type: Stimulants; Non-Stimulants
2) By Age Group: Children; Adults
3) By Gender: Male; Female
4) By Dosage Form: Tablets; Capsules; Other Dosage Forms
5) By Distribution Channel: Retail Pharmacy; Hospital Pharmacy; Online Pharmacy Subsegments:
1) By Stimulants: Methylphenidate-based Medications; Amphetamine-based Medications; Mixed Amphetamine Salts; Dexmethylphenidate
2) By Non-Stimulants: Atomoxetine (Strattera); Guanfacine (Intuniv); Clonidine (Kapvay); Bupropion (Wellbutrin) For further insights on this market,
request a sample here

North America was the largest region in the attention deficit hyperactivity disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the attention deficit hyperactivity disorder market are Pfizer Inc., Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Neos Therapeutics Inc., Collegium Pharmaceutical Inc., Mallinckrodt Pharmaceuticals plc, Tris Pharma Inc., Arbor Pharmaceuticals LLC, Akili Interactive Labs Inc., Mind Medicine (MindMed) Inc., NeuroSigma Inc., KemPharm Inc., RespireRx Pharmaceuticals Inc., Cingulate Therapeutics LLC, Adlon Therapeutics L.P. . For further insights on this market, request a sample here.

Major trends in this market include JAMP Pharma Group Expands ADHD Treatment Options With Launch Of Guanfacine XR. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon